Lets remember that this report is for discussion on the day and will be handed to the committee, including Pharmaxis who will be present along with their representatives, which i believe is some people from the CF committee USA. I guess also that these reports are tough as that is their job to scrutinize... So it will probably boil down to whether Pharmaxis has enogh bullets to fire back at them to satisfy the specialists on the FDA commitee.....
Lets remember that this report is for discussion on the day and...
-
- There are more pages in this discussion • 22 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
